Was ESG a stock market vaccine during COVID-19?
We summarise findings from a recent academic work that investigated whether ESG investing offered funds any resilience during the COVID-19 crisis.
-
-
People Moves (7 Jan): Point72, Numerator and more
In this week's round up, we report on people moves at Point72, Numerator and more. If you'd like to submit your new job or promotion, email us at press@neudata.co. -
B2B IT installs data
NEUDATA VIEW HG Insights estimates the number of software installations and customers of several thousand IT vendors on a monthly basis. The report is based on licensed job posting and resume data, vendor firmographic information, and open source ... -
December Tidbits: 2020 In Review
In our final edition of the year, we discuss some of the most popular themes of 2020, including COVID-19’s impact on alt data collection and usefulness, consumer privacy developments, and dataset discontinuations. -
Receipt data revisited
Transactional data has always been heralded best-in-class alt data. As traditional credit/debit card panels face their own limitations, we revisit e-receipt panels discussed in our previous spotlight article and expand on physical receipt datasets that can provide additional colour on consumer transactions. -
Bloomberg acquires Second Measure
Bloomberg LP has acquired Second Measure, a transactional data provider, to complement its company fundamentals and market data offerings. -
Are government receivables reflected in stock prices?
Below we summarize key findings from a 2020 working paper, which proposes that investors do not promptly incorporate information on government contracts into stock prices. -
Neudata Intelligence 2020: A Year in Review
We recap the ten most-read Intelligence reports of 2020. We also hear directly from Neudata’s analysts to understand why these ten were the breakout reports amongst investors. -
Alt Data for COVID-19: Tracking the Vaccine Rollout
The development and rollout of an effective COVID-19 vaccine is viewed as a key catalyst for the global economic recovery. As a number of vaccines begin to receive regulatory approval, all eyes are on the processes and infrastructure required for vaccine production, procurement, and distribution. We summarise some of the datasets that could be used to track key distribution drivers and success metrics. -
Crowdsourced geopolitical and macroeconomic forecasts
Please note that this report relates to Dysrupt Labs’ “Almanis” app and data derived therefrom, not any other app or affiliated business of Dysrupt. We have not reviewed a sample of the paid data nor reviewed a data dictionary, as Dysrupt has not ...